CTOs on the Move

Helping Hands Family

www.hhfamily.com

 
Helping Hands Family is a group of ABA therapy clinics in PA, NJ, NY, MD, & CT that provides personalized Applied Behavior Analysis (ABA) therapy to help children with autism socialize, learn, and grow.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.hhfamily.com
  • 640, Freedom Business Center Drive
    King of Prussia, PA USA 19406
  • Phone: 484.965.9966

Executives

Name Title Contact Details

Similar Companies

Legacy Retirement Residence

Legacy Retirement Residence is a South Jordan, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OLLY PBC

At OLLY, we believe happiness is an inside job. We know that the right blend of nutrients can help us stay strong, balanced and energetic.

Rexton

Rexton, Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Analytx Solutions

Cardinal Analytx Solutions brings together distinguished innovators and leaders collaboratively advancing into new territory to substantially address one of the most pressing human and economic challenges of our time.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.